Electroencephalography Study Investigating the Effects of Vortioxetine in Healthy Male Subjects
Sponsored by H. Lundbeck A/S
About this trial
Last updated 10 years ago
Study ID
15835A
Status
Completed
Type
Interventional
Phase
Phase 1
Placebo
Yes
Accepting
18 to 45 Years
Male
Trial Timing
Started 11 years ago
What is this trial about?
To explore a neurophysiological marker (electroencephalography) of cognitive effect of
vortioxetine
What are the participation requirements?
Inclusion Criteria
- The subject has a normal resting EEG at screening visit
- The subject is able to perform tasks with an auditory stimulus
- The subject is not visually impaired - normal prescription glasses are accepted
- The subject has a normal circadian rhythm, defined as a person who usually wakes between 6:00 and 9:00 a.m. and goes to sleep between 9:00 pm and midnight.
Exclusion Criteria
- The subject has worked shifts, including night duty, or has travelled across >3 time zones <2 weeks prior to the first dose of IMP. Other inclusion and exclusion criteria may apply.